OMERS Administration Corp’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-104,166
Closed -$1.44M 962
2026
Q1
$1.44M Buy
104,166
+48,000
+85% +$723K 0.01% 578
2025
Q4
$1.01M Buy
56,166
+7,216
+15% +$130K 0.01% 523
2025
Q3
$907K Hold
48,950
0.01% 590
2025
Q2
$783K Buy
48,950
+4,100
+9% +$73.1K 0.01% 563
2025
Q1
$871K Hold
44,850
0.01% 597
2024
Q4
$988K Sell
44,850
-71,210
-61% -$1.37M 0.01% 532
2024
Q3
$1.95M Sell
116,060
-74,400
-39% -$1.1M 0.02% 402
2024
Q2
$2.28M Buy
190,460
+160,760
+541% +$1.8M 0.02% 343
2024
Q1
$329K Buy
+29,700
New +$303K ﹤0.01% 244

Other funds holding CLBT

OMERS Administration Corp's CLBT Position: Q2 2026 in Review

OMERS Administration Corp sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 104,166 shares — an estimated $1.44M sold.

OMERS Administration Corp first reported a position in CLBT in Q1 2024 and held it in 9 quarters. The position peaked at $2.28M in Q2 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • OMERS Administration Corp reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 104,166 Cellebrite shares in Q2 2026, an estimated $1.44M.
  • OMERS Administration Corp first reported a position in Cellebrite in Q1 2024 and held it in 9 quarters.
  • OMERS Administration Corp's Cellebrite position peaked at $2.28M in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.